Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,230.00
Bid: 4,140.00
Ask: 4,230.00
Change: 70.00 (1.68%)
Spread: 90.00 (2.174%)
Open: 4,120.00
High: 4,240.00
Low: 4,120.00
Prev. Close: 4,160.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

18 Jun 2013 15:01

RNS Number : 3195H
North Atlantic Smlr Co Inv Tst PLC
18 June 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 MAY 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 February 2013 to 31 May 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 May 2013

3 months %

6 months %

1 year %

3 years %

5 years %

Diluted NAV*

1,749p

1.6

8.7

22.7

43.5

50.0

Mid-market price

1,440p 

3.3

17.6

55.7

70.8

41.9

Discount to diluted NAV *

17.7% 

Standard & Poor's 500 Composite Index **

1,073.0

7.4

21.3

26.2

43.2

51.9

Russell 2000 **

647.5

7.8

26.1

30.1

42.3

91.9

FTSE All-Share Index

5,090.8

5.0

15.3

30.1

44.1

35.2

US Dollar/Sterling exchange rate

1.5161

0.1

5.4

1.5

(4.4)

23.5

 

* Following the conversion of the Loan Stock, the performance is shown on the diluted NAV (excluding retained revenue for the period) only. The Board considers that this accurately reflects the underlying performance of the Company.

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's Convertible Unsecured Loan Stock 2013 ("the Loan Stock") was all either converted voluntarily by the Loan Stockholders themselves, or was then compulsorily converted by the Trustee of the Loan Stock and subsequently sold with the proceeds from that sale then being distributed rateably to Stockholders. Following this, the Company no longer has any Loan Stock.

 

There have been no material transactions during the quarter ended 31 May 2013.

 

Transaction in Own Shares

 

There have been no transactions in the Company's own shares during the quarter ended 31 May 2013.

 

 

TEN LARGEST INVESTMENTS AT 31 MAY 2013 Percentage of Portfolio

Gleeson (MJ) Group

UK Listed

11.0

US Treasury Bills

US Treasury Bills

10.5

Oryx International Growth Fund Limited *

UK Listed

9.6

Bionostics Holdings Limited

US Unquoted

8.8

Trident Private Equity Fund III LLP

UK Unquoted

7.8

Hampton Investment Properties Limited

UK Unquoted

5.1

Celsis AG

US Unquoted

4.7

Bioquell

UK Listed

3.4

Guinness Peat Group **

UK Listed

3.4

AssetCo PLC

UK Listed

3.3

% of total portfolio

67.6

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 MAY 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

10.1

9.6

19.7

Health Care, Equipment & Services

0.2

11.1

11.3

Construction & Materials

11.0

11.0

Treasury Bills

10.5

10.5

Manufacturing

8.8

8.8

Real Estate

7.5

0.4

7.9

General Financials

4.3

4.3

Support Services

1.3

2.6

3.9

Financial Services

3.4

3.4

Industrial Engineering

3.3

3.3

General Industrials

1.2

1.5

2.7

General Retailers

2.7

2.7

Transportation

2.6

2.6

Media

0.5

1.8

2.3

Travel & Leisure

2.1

2.1

Oil & Gas Producers

1.1

0.8

1.9

Technology Hardware & Equipment

1.6

1.6

 

The financial information for the period ended 31 May 2013 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

18 June 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMVFRLGFZM
Date   Source Headline
15th Jun 20231:15 pmRNSNet Asset Value(s)
26th May 20235:10 pmRNSDirectorate Change
22nd May 20231:37 pmRNSTransaction in Own Shares
22nd May 202310:01 amRNSAnnual Financial Report & Notice of AGM
18th May 202310:58 amRNSNet Asset Value(s)
12th May 20236:25 pmRNSFinal Results
21st Apr 20239:36 amRNSAcquisition of Sureserve Group Plc
19th Apr 20234:10 pmRNSNet Asset Value(s)
6th Apr 20235:16 pmRNSTransaction in Own Shares
31st Mar 20235:07 pmRNSTransaction in Own Shares
23rd Mar 20233:50 pmRNSNet Asset Value(s)
20th Mar 20239:37 amRNSTransaction in Own Shares
13th Mar 20239:54 amRNSTransaction in Own Shares
3rd Mar 20234:42 pmRNSTransaction in Own Shares
20th Feb 202310:24 amRNSTransaction in Own Shares
15th Feb 20234:21 pmRNSNet Asset Value(s)
7th Feb 20235:04 pmRNSDividend Declaration
7th Feb 20233:37 pmRNSDirector/PDMR Shareholding
1st Feb 20234:27 pmRNSTransaction in Own Shares
30th Jan 202310:20 amRNSTransaction in Own Shares
23rd Jan 20239:55 amRNSTransaction in Own Shares
18th Jan 20234:36 pmRNSNet Asset Value(s)
18th Jan 20239:40 amRNSDividend Declaration
16th Jan 20239:51 amRNSTransaction in Own Shares
11th Jan 20235:00 pmRNSTransaction in Own Shares
20th Dec 20227:00 amRNSStatement re Shareholder Engagement
19th Dec 202210:02 amRNSNet Asset Value(s)
25th Nov 202212:20 pmRNSTransaction in Own Shares
18th Nov 202211:59 amRNSNet Asset Value(s)
19th Oct 202210:46 amRNSNet Asset Value(s)
16th Sep 202210:16 amRNSHalf-year Report
15th Sep 20222:18 pmRNSNet Asset Value(s)
6th Sep 20225:01 pmRNSDirectorate Change
15th Aug 20222:34 pmRNSNet Asset Value(s)
22nd Jul 20223:53 pmRNSNet Asset Value(s)
23rd Jun 202210:42 amRNSNet Asset Value(s)
21st Jun 20224:35 pmRNSResult of AGM
15th Jun 20226:33 pmRNSStatement re AGM arrangements
20th May 20223:00 pmRNSAnnual Financial Report & Notice of AGM
16th May 20223:25 pmRNSNet Asset Value(s)
11th May 20225:40 pmRNSFinal Results
19th Apr 202212:15 pmRNSNet Asset Value(s)
14th Mar 202212:07 pmRNSNet Asset Value(s)
28th Feb 20227:00 amRNSDirectorate Change
21st Feb 202211:13 amRNSNet Asset Value(s)
21st Jan 20226:23 pmRNSTransaction in Own Shares amendment
21st Jan 20226:04 pmRNSNet Asset Value(s)
18th Jan 202212:05 pmRNSNet Asset Value(s)
23rd Dec 20214:55 pmRNSStatement re shareholder engagement
16th Dec 202111:30 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.